Finance

Lists
7EY:FRA
Kiora Pharmaceuticals Inc
0,00%
(0,00) 1D
4 հոկ, 23:46:04 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 7EY...
Mkt. cap
11,33 մլն
Volume
0,00
52-wk high
0,42 €
52-wk low
0,42 €
No. of employees
13
Mkt. cap
11,33 մլն
Volume
0,00
52-wk high
0,42 €
52-wk low
0,42 €
No. of employees
13
News stories
From web sources and news partners
About Kiora Pharmaceuticals Inc
CEO-
Employees13
Founded1998
HeadquartersEncinitas, Կալիֆոռնիա, Միացյալ Նահանգներ
Sector-
Websitekiorapharma.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
-
-
-
-
Cost of goods sold
1,07 մլն
1,17 մլն
890,50 հզր
740,85 հզր
Cost of revenue
1,07 մլն
1,17 մլն
890,50 հզր
740,85 հզր
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,44 մլն
1,46 մլն
1,61 մլն
1,38 մլն
Operating expense
1,44 մլն
1,46 մլն
1,61 մլն
1,38 մլն
Total operating expenses
2,52 մլն
2,63 մլն
2,50 մլն
2,12 մլն
Operating income
-2,52 մլն
-2,63 մլն
-2,50 մլն
-2,12 մլն
Other non operating income
-23,71 հզր
173,24 հզր
-47,13 հզր
-11,47 հզր
EBT including unusual items
-616,32 հզր
-7,17 մլն
-2,42 մլն
-2,08 մլն
EBT excluding unusual items
-2,34 մլն
-2,49 մլն
-2,41 մլն
-1,99 մլն
Income tax expense
-643,13 հզր
-649,97 հզր
-
-
Effective tax rate
104,35%
9,07%
-
-
Other operating expenses
-
-
-
-
Net income
26,81 հզր
-6,52 մլն
-2,42 մլն
-2,08 մլն
Net profit margin
-
-
-
-
Earnings per share
0,01
-
-
-
Interest and investment income
201,82 հզր
190,31 հզր
139,34 հզր
146,23 հզր
Interest expense
-
-19,96 հզր
-
-
Net interest expenses
201,82 հզր
170,35 հզր
139,34 հզր
146,23 հզր
Depreciation and amortization charges
-
-
-
-
EBITDA
-2,50 մլն
-2,62 մլն
-2,49 մլն
-2,11 մլն
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps